IBM and Nvidia move quantum processors into supercomputing workflows
New Slurm integration, a Fermilab co-design platform and GPU-accelerated error-correction tools aim to make quantum processors usable inside established HPC environments.
AI / NEWS BRIEF
Anthropic says it will place 5% of its shares in a new public benefit fund, subject to stockholder approval, with a formula that could increase the stake as the company grows.
Anthropic announced that it is committing 5% of its shares to a newly created Anthropic Public Benefit Fund, subject to stockholder approval. The company says its board may add another 2% for each 50% increase in Anthropic's value above a baseline that has not yet been disclosed. Reuters independently reported the central 5% commitment and its approval condition on October 18.
The fund will be a wholly owned limited-liability company rather than a charity. Anthropic says that structure is intended to support different forms of public-benefit spending, potentially including nonprofit grants or direct distributions to specific populations. It says equity held by the fund will not be used for lobbying or political giving. Anthropic also says earlier founder and employee pledges, combined with the new commitment, mean roughly 20% of its shares are dedicated to public benefit, but fuller governance and valuation-trigger details are still forthcoming.
The commitment is unusually large for a frontier AI company and could create a substantial pool for addressing labor disruption, safety research or other social effects if Anthropic's valuation continues to rise. It is not yet a completed transfer: shareholder approval, governance rules, valuation milestones and eventual distributions will determine its real impact. The announcement concerns ownership and public-benefit funding, not model capability, so it provides no basis for changing an AIQuantumScore benchmark or REVAL score.
New Slurm integration, a Fermilab co-design platform and GPU-accelerated error-correction tools aim to make quantum processors usable inside established HPC environments.
OpenAI has released healthcare-focused computer-use capabilities across its API and clinical products, with configurable approvals, audit logs and new performance results that remain provider-reported.